Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Erasca Inc. Common Stock (ERAS) vs National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares (NGG) Price & Performance

Erasca Inc. Common StockTrade
National Grid Transco PLC National Grid PLC (NEW) American Depositary SharesTrade

Price performance (Past 24H)

Key statistics

Erasca Inc. Common Stock vs National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares — how do they compare? Erasca Inc. Common Stock trades at $14.6 (market cap $5.17B), while National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares trades at $78.5 (market cap $78.25B). The key difference: National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares is far larger — about 15.1× Erasca Inc. Common Stock's market cap, and National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares pays a 4.14% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals.

ERASNGG
Market Cap
$5.17B$78.25B
Volume
5,313,3791,070,031
Sector
HealthUtilities
52-Week High
$22.47$93.93
52-Week Low
$2.20$73.54
Typical Hold Time
1 Days—
Enterprise Value
$4.95B$136.28B
Dividend Yield
—4.14%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Erasca Inc. Common Stock

ERAS trades at $14.78, down 4.4% today, with a bullish technical signal from moving averages and a consensus analyst price target of $22.50. The company is a clinical-stage oncology firm with no revenue, reporting a net loss of $124.55 million in 2025, but holds significant liquidity and has three potential registration-enabling trials ahead. Recent news highlights FDA Fast Track designation for its lead candidate ERAS-0015.

The outlook is speculative, driven by clinical trial progress; upside exists if trials succeed, but high cash burn and shareholder investigations pose substantial risks. Investment hinges on binary outcomes from drug development, making it suitable only for risk-tolerant investors focused on biotech.

National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares

National Grid (NGG) trades at $78.23, up 1.44% on the day, with a market cap of approximately $48.3 billion. The stock shows stable technicals near its consensus price target of $79.25. Fundamentally, it maintains strong profitability with an 18.32% net income margin and has beaten EPS estimates in recent quarters. Recent news highlights institutional buying and a focus on grid innovation, including AI adoption.

Outlook is cautiously positive with upside to the high target of $85.50, supported by earnings momentum and strategic investments. Risks include high debt levels and regulatory pressures. Analyst consensus leans buy (55%), but hold ratings reflect concerns over capital intensity and macroeconomic sensitivity.

Returns comparison

Trailing returns across standard periods

About Erasca Inc. Common Stock

Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.

Read more on ERAS →

About National Grid Transco PLC National Grid PLC (NEW) American Depositary Shares

National Grid plc is a British utility company that owns and operates electricity and gas transmission networks in Great Britain, and through its US Regulated business, operates electricity and gas transmission and distribution networks serving customers in New York and Massachusetts. Its shares trade on the NYSE as American Depositary Shares under the ticker NGG.

Read more on NGG →